Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of Enfuvirtide (T-20) in HIV-Infected Children
NCT00022763Phase 2Completed
- Sponsor
- Roche
- Start
- Aug 2001
- Primary completion
- Dec 2004
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of enfuvirtide in human immunodeficiency virus infection (HIV), sponsored by Roche. Primary endpoint: Area Under the Plasma Concentration Time Curve at Week 1. Started Aug 2001; status: completed.
02
Drugs
enfuvirtide
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00022763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00022763.